Chien AJ, Tripathy D, Albain KS, Symmans WF, et al. MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With
Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone
Receptor-Negative Breast Cancers in the I-SPY 2 Trial. J Clin Oncol 2020;38:1059-1069.
PMID: 32031889